<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJAppS</journal-id><journal-title-group><journal-title>Open Journal of Applied Sciences</journal-title></journal-title-group><issn pub-type="epub">2165-3917</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojapps.2019.97046</article-id><article-id pub-id-type="publisher-id">OJAppS-93876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Engineering</subject><subject> Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis, Characterization and &lt;i&gt;In-Vitro&lt;/i&gt; Antimicrobial Studies of M&lt;sup&gt;2+&lt;/sup&gt;+ Complexes of &lt;i&gt;p&lt;/i&gt;-Chlorophenyl-, &lt;i&gt;p&lt;/i&gt;-Bromophenyl-Dithiocarbamates
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Benjamin</surname><given-names>C. Ejelonu</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Chemical Sciences, Adekunle Ajasin University, Akungba-Akoko, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>07</month><year>2019</year></pub-date><volume>09</volume><issue>07</issue><fpage>587</fpage><lpage>594</lpage><history><date date-type="received"><day>9,</day>	<month>April</month>	<year>2019</year></date><date date-type="rev-recd"><day>22,</day>	<month>July</month>	<year>2019</year>	</date><date date-type="accepted"><day>25,</day>	<month>July</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  This study reports the synthesis of metal complexes of mixed ligands 
  p-
  Chlorophenyl-, p-Bromophenyl-dithiocarbamates. The spectral properties of the metal complexes [Zn(II), Cd(II), Hg(II), Cu(II), Co(II) and Ni(II)] were obtained using the FTIR and UV/Vis spectroscopic techniques. Their antibacterial studies revealed that these complexes as well as the ligands could serve as possible antibacterial agents against pathogens. Melting point and solubility measurements were also carried out. It was observed that these complexes were non-toxic, non-electrolytic and stable solids.
 
</p></abstract><kwd-group><kwd>Metal Complexes</kwd><kwd> &lt;i&gt;p&lt;/i&gt;-Chlorophenyl</kwd><kwd> &lt;i&gt;p&lt;/i&gt;-Bromophenyl</kwd><kwd> Dithiocarbamates</kwd><kwd>  Antibacterial Studies</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Dithiocarbamate is a group of organic compound, an analogue of carbamates in which both oxygen atoms are replaced by sulphur atoms [<xref ref-type="bibr" rid="scirp.93876-ref1">1</xref>] . The transition metal complexes (TMCs) of dithiocarbamates have been reported and applied in different areas of material science [<xref ref-type="bibr" rid="scirp.93876-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref4">4</xref>] . This is due to their stability in different oxidation states [<xref ref-type="bibr" rid="scirp.93876-ref5">5</xref>] . Metal complexes of dithiocarbamates have been studied extensively due to their biological, agricultural, chemical, medicinal, pharmaceutical and industrial applications [<xref ref-type="bibr" rid="scirp.93876-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref6">6</xref>] . The presence of the dithiocarbamate moiety in some biologically active molecules has generated interest in their potentials for medical application [<xref ref-type="bibr" rid="scirp.93876-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref11">11</xref>] . Development of metal based pharmaceuticals has received tremendous attention due to increased resistance to current generation of antibiotics by pathogens [<xref ref-type="bibr" rid="scirp.93876-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref14">14</xref>] . The TMCs of mixed ligands have been used in past and recent times for optimal applications especially in the area of medicine [<xref ref-type="bibr" rid="scirp.93876-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref15">15</xref>] . This work was therefore designed to synthesize, characterize and evaluate the antimicrobial activities of mixed ligands p-Chlorophenyl- and p-Bromophenyl-dithiocarbamates metal complexes.</p><p>Thiocarbamate itself has been synthesized and characterized and reported for its potency against bacteria such as Escherchia coli, Staphylococcus aureus, Bactillus subtilis etc. and fungi such as Aspergillus niger, Monilia americana, Candida albicans etc. [<xref ref-type="bibr" rid="scirp.93876-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref16">16</xref>] . Also, a lot of metals have been reported for their medicinal and pharmaceutical applications. Bringing them together with ligands like the thiocarbamates creates synergistic effects for improved efficiency [<xref ref-type="bibr" rid="scirp.93876-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.93876-ref16">16</xref>] .</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>All chemicals and reagents used are analytical grade with no further purification needed. They include methanol, carbon disulphide, ammonium solution, toluene, ethanol, phosphorus pentaoxide, sodium carbonate, chloroacetic acid, p-chlorophenyl amine, p-bromophenyl amine. The Gallen Kamp melting point apparatus was used to determine the melting points of the synthesized metal complexes. The Uv-vis measurements of the metal complexes were recorded in DMSO using Perkin Elmer Lambda 25 spectrophotometer from 800 - 200 cm<sup>−1</sup>, while the FTIR data were obtained by using KBr discs on a Perkin Elmer 2000 FT-IR spectrophotometer in the range 4000 - 370 cm<sup>−1</sup>.</p><sec id="s2_1"><title>2.1. Synthesis of the Ligands</title><sec id="s2_1_1"><title>2.1.1. Synthesis of Ammonium p-Chlorophenyl Dithiocarbamate Ligand, L1</title><p>9.6 g of p-chloroaniline, 6 ml of carbon disulphide and 11ml of ammonium hydroxide were added into a 250 ml round bottom flask fitted to a reflux condenser, magnetic stirrer and thermometer. The mixture was stirred vigorously, the reaction was maintained at 30˚C - 35˚C by external cooling, a heavy yellow precipitate of ammonium p-chlorophenyl dithiocarbamate was separated out. The mixture was filtered and residue washed off with 30 ml portion of a 3% aqueous solution of ammonium chloride and with two 15 ml portions of 96% ethanol, dried in a desiccator (sodium hydroxide and phosphorus pentoxide as desiccant) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s2_1_2"><title>2.1.2. Synthesis of Ammonium p-Bromophenyl Dithiocarbamate Ligand, L2</title><p>9.92 g of p-bromoaniline, 15 ml of carbon disulphide and 15 ml of ammonium hydroxide were added into a 250 ml round bottom flask fitted to a reflux condenser, magnetic stirrer and thermometer. The mixture was stirred vigorously, the reaction was maintained at 30˚C - 35˚C by external cooling, initially, the mixture turned milky and suddenly, a deep red was obtained. At the end of the</p><p>reaction, a foamy heavy orange precipitate of a heavy yellow precipitate of ammonium p-bromophenyl dithiocarbamate was separated out. The mixture was filtered and residue washed off with 30 ml portion of a 3% aqueous solution of ammonium chloride and with two 15 ml portions of 96% ethanol, dried in a desiccator (sodium hydroxide and phosphorus pentoxide as desiccant) (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s2_1_3"><title>2.1.3. Synthesis of M<sup>2+</sup> Complexes of p-Chlorophenyl Dithiocarbamate and p-Bromophenyl Dithiocarbamate Ligand</title><p>0.2017 g of Zinc (II) sulphate, 0.5202 g of cadmium (II) chloride, 0.214 g of mercury (II) chloride, 0.1995 g of Copper (II) sulphate, 0.297 g of cobalt (II) chloride and 0.3285 g of nickel (II) chloride were weighed and transferred into a 250 ml beaker each. 50ml of distilled water was added into each beaker with a magnetic bar for effective stirring. Also, 0.276 g of p-chlorophenyl dithiocarbamate and 0.331 g of p-bromophenyl dithiocarbamate were out into 100 ml beakers each. 50 ml distilled water was added and each solution stirred on a magnetic stirrer after which the two ligands were poured into each salt solution simultaneously and step-wisely. The ligand/metal solution mixtures were then stirred vigorously for 3 hours each. A whitish precipitate was obtained for zinc (II) complex, yellowish precipitate for cadmium (II) complex, black precipitate for mercury (II) complex, a dark brown precipitate for copper (II) complex, purple precipitate for cobalt (II) complex and greenish yellow precipitate for nickel (II) complex. Individual products were suctioned and dried in a desiccator (using the mixture of sodium hydroxide and phosphorus pentoxide as desiccant) and weighed (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec></sec><sec id="s2_2"><title>2.2. Biological Activities</title>Antibacterial Assay (In Vitro)<p>The ligands and their metal complexes were screened in vitro for their antibacterial potencies against gram positive and gram negative bacteria (Escherichia coli, Serratia mercescens, Salmonella tyhi, Shigella flexneri and Staphylococcus aereus) and fungi (Trichoderma viride, Monilia albicans, Saccharomycodes ludwigii, Rhizopus stolon and Mucor mucedo). These compounds were dissolved in DMSO. Two-eight hour old bacterial inoculums containing approximately 10<sup>4</sup> - 10<sup>6</sup> colony forming units (CFU/ml) were used. Wells of 0.8 mm in diameter</p><p>were dug in the media with the aid of a sterile metallic cork borer. The test organisms were inoculated into disposable plates, each well bored at four equidistant peripheral points and inoculation was repeated three times. The wells were filled with 1 mg/ml and 10 μg/ml for bacteria and fungi respectively of the complex solutions. DMSO and reference antibacterial and antifungal drugs (tetracycline and amphotericin respectively) were used as standard drugs. The organisms were grown on Meuller Hinton and potato dextrose (Agar) for bacteria and fungi respectively at 37˚C for 48 hours (bacteria) and at 30˚C for seven days (fungi).</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Physical Parameters</title><p>Electro Thermal Digital melting point apparatus was used to obtain the melting points of the ligands and TMCs. The percentage yields values of the ligands and TMCs were relatively high (76% - 92%). The melting points showed that the compounds are stable in solid states (<xref ref-type="table" rid="table1">Table 1</xref>). The ligands were soluble in water, polar organic solvents and sparingly soluble in non-polar organic solvents. The TMCs were insoluble in water, but soluble in most organic solvents (<xref ref-type="table" rid="table2">Table 2</xref>). The solubility test suggests that the synthesized compounds are non-polar.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Melting point measurements/yield percentage for both the ligands and their respective metal complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Ligands/metal complexes</th><th align="center" valign="middle" >Melting points (˚C)</th><th align="center" valign="middle" >Yield percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >p-chlorophenyl dithiocarbamate</td><td align="center" valign="middle" >122</td><td align="center" valign="middle" >92</td></tr><tr><td align="center" valign="middle" >p-bromophenyl dithiocarbamate</td><td align="center" valign="middle" >156</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >Zn<sup>2+</sup> complex</td><td align="center" valign="middle" >182</td><td align="center" valign="middle" >78</td></tr><tr><td align="center" valign="middle" >Cd<sup>2+</sup> complex</td><td align="center" valign="middle" >268</td><td align="center" valign="middle" >79</td></tr><tr><td align="center" valign="middle" >Hg<sup>2+</sup> complex</td><td align="center" valign="middle" >134</td><td align="center" valign="middle" >76</td></tr><tr><td align="center" valign="middle" >Cu<sup>2+</sup> complex</td><td align="center" valign="middle" >184</td><td align="center" valign="middle" >67</td></tr><tr><td align="center" valign="middle" >Co<sup>2+</sup> complex</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >71</td></tr><tr><td align="center" valign="middle" >Ni<sup>2+</sup> complex</td><td align="center" valign="middle" >266</td><td align="center" valign="middle" >72</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The solubility tests for the synthesized ligands and their metal complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Solvents</th><th align="center" valign="middle"  colspan="2"  >Ligands</th><th align="center" valign="middle"  colspan="6"  >Metal complexes</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >p-bromophenyl DTC</td><td align="center" valign="middle" >p-chlorophenyl DTC</td><td align="center" valign="middle" >Zn(II)</td><td align="center" valign="middle" >Cd(II)</td><td align="center" valign="middle" >Hg(II)</td><td align="center" valign="middle" >Cu(II)</td><td align="center" valign="middle" >Co(II)</td><td align="center" valign="middle" >Ni(II)</td></tr><tr><td align="center" valign="middle" >Toluene</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Insoluble</td></tr><tr><td align="center" valign="middle" >Methanol</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Partially soluble</td></tr><tr><td align="center" valign="middle" >Ethanol</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td></tr><tr><td align="center" valign="middle" >Chloroform</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Sparingly soluble</td></tr><tr><td align="center" valign="middle" >Xylene</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td></tr><tr><td align="center" valign="middle" >Ethyl acetate</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Partially soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td></tr><tr><td align="center" valign="middle" >Acetone</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Sparingly soluble</td></tr><tr><td align="center" valign="middle" >Propan-2-ol</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td></tr><tr><td align="center" valign="middle" >DMSO</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Sparingly soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td></tr><tr><td align="center" valign="middle" >Water</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Soluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td><td align="center" valign="middle" >Insoluble</td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. Spectroscopic Studies</title><p>The results of the FTIR spectroscopy (<xref ref-type="table" rid="table3">Table 3</xref>) showed absorption peaks for the ligands and the TMCs for v(C-N) at range 1488 - 1489 cm<sup>−1</sup>. v(C-S) at range 931 - 997 cm<sup>−1</sup>, the single band at this region is related to the bidentate coordination as revealed by previous researchers (Mcelwa, 2013), v(N-H) at range 3143 - 3440 cm<sup>−1</sup>. The most important absorption at 600 - 900 cm<sup>−1</sup> as observed in related works (Sunitha et al., 2011) is the most important one resulting from the out of plane bending vibration. 720 cm<sup>−1</sup> was observed for v(=C-H) bending modes of the aromatic ring (p-chlorophenyl dithiocarbamate) while 820 cm<sup>−1</sup> was observed for that of (p-bromophenyl dithiocarbamate).</p><p>The electronic spectra of the ligands and TMCs were recorded in DMSO using a Lamda Perkin Spectrometer. Zn (II) absorbed at around (244, 299 and 340 nm), Cd (II) at (268 and 328 nm), Hg (II) at (243 and 320 nm), Cu (II) at [261, 320, both due to intra ligand charge transfer and 402 (d-d transition) nm], Co (II) at [245, 323, both due to intra ligand charge transfer, 388 (metal to ligand charge transfer), 620 (d-d transition) nm] and Ni (II) at [(254 and 326), due to intraligand charge transfer, (386 and 435, medium bands due to metal to ligand charge transfer), (490 and 640, weak bands due to d-d transition) nm]. The transitions in Zn (II), Cd (II), Hg (II) are due to intraligand charge transfer and metal to ligand charge transfer.</p></sec><sec id="s3_3"><title>3.3. Antimicrobial Assay</title><p>The antimicrobial activity of the ligands and TMCs were investigated in vitro against some selected bacteria such as Escherichia coli, Serratia mercescens and Staphylococcus aereus. From <xref ref-type="table" rid="table4">Table 4</xref> and <xref ref-type="table" rid="table5">Table 5</xref>, they showed good activity against the bacterial infections, with Cd (II), Hg (II), Co (II) and Cu (II) showing better activities than the ligands and standard drug. The TMCs were poor against the fungal infections.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> FTIR results of the ligands and TMCs in cm<sup>−1</sup></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Ligands/Metal complexes</th><th align="center" valign="middle" >V(C-N)</th><th align="center" valign="middle" >V(C-S)</th><th align="center" valign="middle" >V(N-H)</th></tr></thead><tr><td align="center" valign="middle" >L1</td><td align="center" valign="middle" >1489</td><td align="center" valign="middle" >994</td><td align="center" valign="middle" >3428</td></tr><tr><td align="center" valign="middle" >L2</td><td align="center" valign="middle" >1485</td><td align="center" valign="middle" >994</td><td align="center" valign="middle" >3440</td></tr><tr><td align="center" valign="middle" >Zn(II)</td><td align="center" valign="middle" >1490</td><td align="center" valign="middle" >997</td><td align="center" valign="middle" >3274</td></tr><tr><td align="center" valign="middle" >Cd(II)</td><td align="center" valign="middle" >1488</td><td align="center" valign="middle" >991</td><td align="center" valign="middle" >3240</td></tr><tr><td align="center" valign="middle" >Hg(II)</td><td align="center" valign="middle" >1498</td><td align="center" valign="middle" >931</td><td align="center" valign="middle" >3143</td></tr><tr><td align="center" valign="middle" >Cu(II)</td><td align="center" valign="middle" >1490</td><td align="center" valign="middle" >976</td><td align="center" valign="middle" >3264</td></tr><tr><td align="center" valign="middle" >Co(II)</td><td align="center" valign="middle" >1496</td><td align="center" valign="middle" >1005</td><td align="center" valign="middle" >3445</td></tr><tr><td align="center" valign="middle" >Ni(II)</td><td align="center" valign="middle" >1528</td><td align="center" valign="middle" >996</td><td align="center" valign="middle" >3205</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> The zones of inhibition of the ligands and their metal complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Pathogens</th><th align="center" valign="middle"  colspan="2"  >Ligands</th><th align="center" valign="middle"  colspan="6"  >Metal complexes</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >L1</td><td align="center" valign="middle" >L2</td><td align="center" valign="middle" >Zn(II)</td><td align="center" valign="middle" >Cd(II)</td><td align="center" valign="middle" >Hg(II)</td><td align="center" valign="middle" >Cu(II)</td><td align="center" valign="middle" >Co(II)</td><td align="center" valign="middle" >Ni(II)</td><td align="center" valign="middle" >Standard drug (+ve control)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Bacteria</td><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >S. mercescens</td><td align="center" valign="middle" >1.7</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >2.7</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >1.9</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >S. aureus</td><td align="center" valign="middle" >3.2</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >1.9</td><td align="center" valign="middle" >1.9</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >3.2</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Fungi</td><td align="center" valign="middle" >T. viride</td><td align="center" valign="middle" >2.5</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >3.1</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >M. albicans</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >2.5</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> The minimum inhibitory concentrations of the ligands and their metal complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Pathogens</th><th align="center" valign="middle"  colspan="2"  >Ligands</th><th align="center" valign="middle"  colspan="6"  >Metal complexes</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >L1</td><td align="center" valign="middle" >L2</td><td align="center" valign="middle" >Zn(II)</td><td align="center" valign="middle" >Cd(II)</td><td align="center" valign="middle" >Hg(II)</td><td align="center" valign="middle" >Cu(II)</td><td align="center" valign="middle" >Co(II)</td><td align="center" valign="middle" >Ni(II)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Bacteria</td><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >none</td></tr><tr><td align="center" valign="middle" >S. mercescens</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >none</td></tr><tr><td align="center" valign="middle" >S. aureus</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Fungi</td><td align="center" valign="middle" >T. viride</td><td align="center" valign="middle" >2.5</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >2.5</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td></tr><tr><td align="center" valign="middle" >M. albicans</td><td align="center" valign="middle" >2.5</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td><td align="center" valign="middle" >none</td></tr></tbody></table></table-wrap><p>NB: MIC of standard antibacterial drug (tetracycline) = 0.25 mg/ml while antifungal drug (amphoterin B) is 2.5 μg/ml.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>This study showed that some ligands and metal complexes synthesized could be used as potent drugs against the tested bacterial infections. Further studies however, are needed to ascertain their toxicity status and compatibility with human physiology.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Ejelonu, B.C. (2019) Synthesis, Characterization and In-Vitro Antimicrobial Studies of M<sup>2+</sup> Complexes of p-Chlorophenyl-, p-Bromophenyl-Dithiocarbamates. Open Journal of Applied Sciences, 9, 587-594. https://doi.org/10.4236/ojapps.2019.97046</p></sec></body><back><ref-list><title>References</title><ref id="scirp.93876-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Schubart, ü. (2000) Dithiocarbamic Acid and Derivatives. Ullmann’s Encyclopedia of Industrial Chemistry. Wiley-VCH, Weinheim.  
https://doi.org/10.1002/14356007.a09_001</mixed-citation></ref><ref id="scirp.93876-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Nqombolo, A. and Ajibade, P.A. (2016) Synthesis and Spectral Studies of Ni(II) Dithiocarbamate Complexes and Their Use as Precursors for Nickel Sulphides Nanocrystals. Journal of Chemistry, 2016, Article ID: 1293790.  
https://doi.org/10.1155/2016/1293790</mixed-citation></ref><ref id="scirp.93876-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Odularu, A.T. and Ajibade, P.A. (2019) Dithiocarbamates: Challenges, Control, and Approaches to Excellent Yield, Characterization, and Their Biological Applications. Bioinorganic Chemistry and Applications, 2019, Article ID: 8260496.  
https://doi.org/10.1155/2019/8260496</mixed-citation></ref><ref id="scirp.93876-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Regulacio, M.D., Tomson, N. and Stoll, S.L. (2005) Dithiocarbamate Precursors for Rare-Earth Sulfides. Chemistry of Materials, 17, 3114-3121.  
https://doi.org/10.1021/cm0478071</mixed-citation></ref><ref id="scirp.93876-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ejelonu, B.C., Olagboye, S.A., Oyeneyin, O.E., Ebiesuwa, O.A. and Bada, O.E. (2018) Synthesis, Characterization and Antimicrobial Activities of Sulfadiazine Schiff Base and Phenyl Dithiocarbamate Mixed Ligand Metal Complexes. Open Journal of Applied Sciences, 8, 346-354. https://doi.org/10.4236/ojapps.2018.88026</mixed-citation></ref><ref id="scirp.93876-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Warra</surname><given-names> A.A. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>Transition Metal Complexes and Their Application in Drugs and Cosmetics—A Review</article-title><source> Journal of Chemical and Pharmaceutical Research</source><volume> 3</volume>,<fpage> 951</fpage>-<lpage>958</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.93876-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mattarei, A., Azzolini, M., La Spina, M., Zoratti, M., Paradisi, C. and Biasutto, L. (2015). Amino Acid Carbamates as Prodrugs of Resveratrol. Scientific Reports, 5, Article No. 15216. https://doi.org/10.1038/srep15216</mixed-citation></ref><ref id="scirp.93876-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ghosh, A.K. and Brindisi, M. (2015) Organic Carbamates in Drug Design and Medicinal Chemistry. Journal of Medicinal Chemistry, 58, 2895-2940.  
https://doi.org/10.1021/jm501371s</mixed-citation></ref><ref id="scirp.93876-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Vacondio, F., Silva, C., Mor, M. and Testa, B. (2010) Qualitative Structure-Metabolism Relationships in the Hydrolysis of Carbamates. Drug Metabolism Reviews, 42, 551-589. https://doi.org/10.3109/03602531003745960</mixed-citation></ref><ref id="scirp.93876-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Jornada, D.H., dos Santos Fernandes, G.F., Chiba, D.E., de Melo, T.R.F., dos Santos, J.L. and Chung, M.C. (2016) The Prodrug Approach: A Successful Tool for Improving Drug Solubility. Molecules, 21, 42.  
https://doi.org/10.3390/molecules21010042</mixed-citation></ref><ref id="scirp.93876-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mata, G., do Rosário, V.E., Iley, J., Constantino, L. and Moreira, R. (2011) A Carbamate-Based Approach to Primaquine Prodrugs: Antimalarial Activity, Chemical Stability and Enzymatic Activation. Bioinorganic and Medicinal Chemistry, 20, 886-892.  
https://doi.org/10.1016/j.bmc.2011.11.059</mixed-citation></ref><ref id="scirp.93876-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Saha, S., Dhanasekaran, D., Chandraleka, S., et al. (2010) Synthesis, Characterization and Antimicrobial Activity of Cobalt Metal Complex against Drug Resistant Bacterial and Fungal Pathogens. Advances in Biological Research, 4, 224-229.</mixed-citation></ref><ref id="scirp.93876-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Reiss, A., Chifiriuc, M.C., Amzoiu, E. and Sp&amp;#238;nu, C.I. (2014) Ransition Metal(II) Complexes with Cefotaxime-Derived Schiff Base: Synthesis, Characterization, and Antimicrobial Studies. Bioinorganic Chemistry and Applications, 2014, Article ID: 926287. https://doi.org/10.1155/2014/926287</mixed-citation></ref><ref id="scirp.93876-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ajibade, P.A. and Idemudia, O.G. (2013) Synthesis, Characterization, and Antibacterial Studies of Pd(II) and Pt(II) Complexes of Some Diaminopyrimidine Derivatives. Bioinorganic Chemistry and Applications, 2013, Article ID: 549549.  
https://doi.org/10.1155/2013/549549</mixed-citation></ref><ref id="scirp.93876-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ejelonu, B.C., Oyeneyin, O.E., Olagboye, S.A. and Akele, O.E. (2018) Synthesis, Characterization and Antimicrobial Properties of Transition Metal Complexes of Aniline and Sulphadiazine Schiff Bases as Mixed Ligands. Journal of Chemical and Pharmaceutical Research, 10, 67-73.</mixed-citation></ref><ref id="scirp.93876-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Rubner, G., Bensdorf, K., Wellner, A., Kircher, B., Bergemann, S., Ott, I. and Gust, R. (2010) Synthesis and Biological Activities of Transition Metal Complexes Based on Acetylsalicylic Acid as Neo-Anticancer Agents. Journal of Medicinal Chemistry, 53, 6889-6898. https://doi.org/10.1021/jm101019j</mixed-citation></ref></ref-list></back></article>